🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9273124

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9272051

Methods and systems for modulating hormones and related methods, agents and compositions

The United States Government represented by the Department of Veterans Affairs · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9272009

Method for increasing performance of offspring

JBS UNITED, INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9272023

Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266928

Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved ant

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266960

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9265818

Genetically modified Babesia parasites expressing protective tick antigens and uses thereo

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9259452

Deacetylase inhibitor therapy

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9259463

Chlamydia vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260504

N- and C-terminal substituted antagonistic analogs of GH-RH

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9254316

Adenoviral vector-based malaria vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9254319

Compositions and methods for generating an immune response

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248179

Pan-lyssavirus vaccines against rabies

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9249217

Bispecific EGFRvIII x CD3 antibody engaging molecules

The United States of America, as represented by the Secretary, DHHS · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248145

Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and c

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9241981

Use of a food additive based on at least one phytonutrient for stimulating vaccine immunit

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243036

Anti-microbial activity of synthetic peptides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238799

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238800

Avian adenoassociated virus and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238069

Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in c

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238684

SPANX-B polypeptides and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9234179

Materials and methods for generating pluripotent stem cells

SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted